Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.710
-0.290 (-14.50%)
At close: Nov 13, 2026, 4:00 PM EST
1.700
-0.010 (-0.58%)
After-hours: Nov 13, 2026, 7:56 PM EST
Adagene Market Cap
Adagene has a market cap or net worth of $114.82 million as of November 13, 2026. It is the 24,017th most valuable company in the world and the 3,944th biggest in the United States. Its market cap has increased by 37.63% in one year.
Market Cap
114.82M
Enterprise Value
-7.00M
1-Year Change
37.63%
Global Rank
Country Rank
#3,944 United States
Category
ChartMarket Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $114.82M, a decrease of -85.72%. That is a compound annual growth rate of -28.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 114.82M | 28.89% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 127.15M |
| Codexis | 127.13M |
| Spruce Biosciences | 124.47M |
| Foghorn Therapeutics | 124.12M |
| Innate Pharma | 124.08M |
| Zura Bio | 119.44M |
| Cue Biopharma | 117.10M |
| Minerva Neurosciences | 114.62M |